本頁面由Tiger Trade Technology Pte. Ltd.提供服務

萬達生物製藥

5.13
+0.02000.39%
盤後5.03-0.1000-1.95%19:30 EDT
成交量:165.86萬
成交額:848.27萬
市值:3.10億
市盈率:-1.11
高:5.15
開:5.09
低:5.04
收:5.11
52周最高:9.94
52周最低:4.27
股本:6,046.27萬
流通股本:4,766.05萬
量比:2.46
換手率:3.48%
股息:- -
股息率:- -
每股收益(TTM):-4.6291
每股收益(LYR):-3.7413
淨資產收益率:-77.81%
總資產收益率:-22.38%
市淨率:1.41
市盈率(LYR):-1.37

資料載入中...

2026/08/19

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/13

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/06/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/05

重要事件披露

Form 8-K - Current report
2026/05/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/29

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/25

SEC問詢函

Form CORRESP - Correspondence
2026/04/22

重要事件披露

Form 8-K - Current report
2026/04/03

重要事件披露

Form 8-K - Current report
2026/03/11

重要事件披露

Form 8-K - Current report
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities